Overcoming the hurdles of randomised clinical trials of therapeutic cancer vaccines
Authors:
- 1 June 2010
- journal article
- review article
- Published by Elsevier in European Journal of Cancer
- Vol. 46 (9) , 1514-1519
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Update on castrate-resistant prostate cancer: 2010Current Opinion in Oncology, 2010
- The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational ResearchClinical Cancer Research, 2009
- Therapeutic vaccines in solid tumours: Can they be harmful?European Journal of Cancer, 2009
- The cancer vaccine roller coasterNature Biotechnology, 2009
- Recent Advances in Cancer Vaccines: An OverviewJapanese Journal of Clinical Oncology, 2008
- A review of prophylactic human papillomavirus vaccines: Recommendations and monitoring in the USCancer, 2008
- Paradigm Shifts in Cancer Vaccine TherapyExperimental Biology and Medicine, 2008
- Lessons from randomized phase III studies with active cancer immunotherapies – Outcomes from the 2006 Meeting of the Cancer Vaccine Consortium (CVC)Vaccine, 2007
- More than one reason to rethink the use of peptides in vaccine designNature Reviews Drug Discovery, 2007
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991